Brigitte Gasser

Dr. Brigitte Gasser

Institute of Biotechnology, Universitat fur Bodenkultur Wien, Vienna, Austria

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TGThomas Gassler
Thomas Gassler
MSMichael Sauer
Michael Sauer
BGBrigitte Gasser
Brigitte Gasser
MEMichael Egermeier
Michael Egermeier
CTChristina Troyer
Christina Troyer
MSMatthias G. Steiger
Matthias G. Steiger

4 April 2008 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
BGBrigitte Gasser
Brigitte Gasser
MSMarkku Saloheimo
Markku Saloheimo
URUrsula Rinas
Ursula Rinas
MDMartin Dragosits
Martin Dragosits
EREscarlata Rodríguez-Carmona
Escarlata Rodríguez-Carmona
AVAntonio P Villaverde
Antonio P Villaverde
Different species of microorganisms including yeasts, filamentous fungi and bacteria have been used in the past 25 years for the controlled production of foreign proteins of scientific, pharmacological or industrial interest. A major obstacle for protein production processes and a limit to overall success has been the abundance of misfolded polypeptides, which fail to reach their native conformation. The presence of misfolded or folding-reluctant protein species causes considerable stress in host cells. The characterization of such adverse conditions and the elicited cell responses have permitted to better understand the physiology and molecular biology of conformational stress. Therefore, microbial cell factories for recombinant protein production are depicted here as a source of knowledge that has considerably helped to picture the extremely rich landscape of in vivo protein folding, and the main cellular players of this complex process are described for the most important cell factories used for biotechnological purposes.

21 November 2011
Verified
Book Chapter
Closed access
PDF file
DMDiethard Mattanovich
Diethard Mattanovich
PBPaola Branduardi
Paola Branduardi
LDLaura Dato
Laura Dato
BGBrigitte Gasser
Brigitte Gasser
MSMichael Sauer
Michael Sauer
Danilo PorroDanilo Porro
Danilo Porro

29 December 2003 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
HHHubertus Hohenblum
Hubertus Hohenblum
BGBrigitte Gasser
Brigitte Gasser
MMMichael Maurer
Michael Maurer
NBNicole Borth
Nicole Borth
DMDiethard Mattanovich
Diethard Mattanovich

1 November 2013 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
MDMarizela Delic
Marizela Delic
MVMinoska Valli
Minoska Valli
AGAlexandra Bettina Graf
Alexandra Bettina Graf
MPMartin Pfeffer
Martin Pfeffer
DMDiethard Mattanovich
Diethard Mattanovich
BGBrigitte Gasser
Brigitte Gasser
Protein secretion in yeasts is a complex multistep process involving several hundreds of genes. Comparative genomics enables a detailed overview of conserved fu

1 February 2013 in Future Microbiology
Verified
Journal Article
Closed access
BGBrigitte Gasser
Brigitte Gasser
RPRoland Prielhofer
Roland Prielhofer
HMHans Marx
Hans Marx
MMMichael Maurer
Michael Maurer
JNJustyna Nocon
Justyna Nocon
DMDiethard Mattanovich
Diethard Mattanovich
Pichia pastoris is the most frequently used yeast system for heterologous protein production today. The last few years have seen several products based on this platform reach approval as biopharmaceutical drugs. Successful glycoengineering to humanize N-glycans is further fuelling this development. However, detailed understanding of the yeast's physiology, genetics and regulation has only developed rapidly in the last few years since published genome sequences have become available. An expanding toolbox of genetic elements and strains for the improvement of protein production is being generated, including promoters, gene copy-number enhancement, gene knockout and high-throughput methods. Protein folding and secretion have been identified as significant bottlenecks in yeast expression systems, pinpointing a major target for strain optimization. At the same time, it has become obvious that P. pastoris, as an evolutionarily more 'ancient' yeast, may in some cases be a better model for human cell biology and disease than Saccharomyces cerevisiae.